TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
WINDSOR, Conn., Jan. 29, 2018 -- Scapa Healthcare, a leading strategic outsource partner of skin friendly turn-key solutions, today announced the availability of Scapa Soft-Pro® Low Trauma Hydrocolloid, a proprietary, gentle adhesive with repositionable properties for sensitive skin applications. This latest addition to the extensive Scapa Soft-Pro® portfolio of skin contact adhesives is suitable for medical device fixation, advanced wound care and consumer wellness applications for those with fragile skin. It is ideal for a full spectrum of users ranging from pediatric and neonatal to geriatric populations.
Scapa’s Soft-Pro® Low Trauma Hydrocolloid utilizes a unique formulation that flows with the skin to prevent discomfort and damage, while remaining securely fixed. It is biocompatible, latex free and gamma stable. The adhesive is both breathable and absorbent, allowing it to manage normal skin perspiration for multi-day wear times. The low trauma hydrocolloid can be gently lifted and reapplied without pulling body hair, leaves little to no residue, and is easily repositionable while maintaining strong securement on the skin.
“As a leader in skin friendly adhesive solutions, we continually strive to develop innovative products that provide superior functionality to meet end-user needs,” said Michael Muchin, Scapa Healthcare’s VP of Product Development. “We understand the complexities of the skin as it changes with age. Scapa Soft-Pro® Low Trauma Hydrocolloid is the optimal choice for users with fragile skin – such as newborns and the elderly – that require a repositionable adhesive with secure fixation capabilities.”
Scapa Healthcare will be exhibiting its comprehensive product portfolios and end-to-end services and capabilities for complete, innovative adhesive solutions in booth 3291 at MD&M West.
About Scapa Healthcare
Scapa Healthcare is a global strategic outsource partner of skin friendly turn-key solutions for advanced wound care, consumer wellness and medical device fixation markets. Scapa Healthcare partners with market leaders to design, develop, manufacture and commercialize innovative skin contact solutions to meet end-user needs. For more information, visit: www.scapahealthcare.com
Media Contact Jordan Bouclin SVM Public Relations and Marketing Communications [email protected] (401)490-9700 Marketing Contact Beth Schivley Marketing Communications Manager, Scapa Healthcare [email protected] 860-688-8000
